Those are my thoughts as well. If I am Amarantu
Post# of 30028
If I am Amarantus, I think I would want to get Lympro so dialed in and proven to be such a valuable diagnostic that I would want BP to bid for it. Because if I am a certain BP heavy into ALZ research and drug development, why would I want a diagnostic that can better screen for ALZ in the hands of a competitor? I wouldn't. My hope is that once Lympro is actually field tested and BPs see what a gem it is as they use it during their initial screening, it will touch off a frenzied bidding war for the diagnostic. That's the rosy scenario I am dreaming of.